Latest news

BioVersys Announces First Subjects Dosed in Phase 1 Clinical Trial of BVL-GSK098

January 12, 2021/by l.loewenau

Call for preclinical and clinical data sets

July 30, 2020/by Clément Robijns

BioVersys receives QIDP designation for BVL-GSK098 and ETH

July 13, 2020/by l.loewenau

Successful First Annual Meeting for IMI project GNA NOW

July 10, 2020/by l.loewenau

see all news

Newsletter

Your subscription could not be saved. Please try again.
Your subscription has been successful.


Your e-mail address will be used solely for communication purposes by the AMR Accelerator projects. You will be able to unsubscribe at any time and thereby revoke your consent to receive the newsletter. A transfer of the data to third parties will not occur. For further information, please refer to our privacy policy.